Related Experiment Video

Updated: Feb 15, 2026

Derivation of Hematopoietic Stem Cells from Murine Embryonic Stem Cells
22:06

Derivation of Hematopoietic Stem Cells from Murine Embryonic Stem Cells

Published on: February 25, 2007

14.0K

Development of Stem-Cell-Mobilizing Agents Targeting CXCR4 Receptor for Peripheral Blood Stem Cell Transplantation

Chien-Huang Wu1, Jen-Shin Song1, Hsuan-Hao Kuan1

  • 1Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes , Miaoli County 35053, Taiwan, R.O.C.

Journal of Medicinal Chemistry
|January 10, 2018
PubMed

Insights

Researchers developed novel pyrimidine-based CXCR4 antagonists. Compound 16 demonstrated superior HSC-mobilizing ability compared to AMD3100, indicating potential for PBSCT applications.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Molecular Biology

Background:

  • The CXCR4/CXCL12 signaling pathway is implicated in various diseases, including cancer metastasis, inflammation, and tissue regeneration.
  • CXCR4 antagonists can mobilize CXCR4-expressing cells from bone marrow to peripheral circulation, a process relevant for hematopoietic stem cell transplantation (HSCT).

Purpose of the Study:

  • To discover and characterize novel pyrimidine-based antagonists targeting the CXCR4 receptor.
  • To evaluate the efficacy of these novel compounds in mobilizing hematopoietic stem cells (HSCs).

Main Methods:

  • Synthesis and characterization of a novel series of pyrimidine-based compounds.
  • In vitro and in vivo evaluation of CXCR4 antagonist activity and HSC-mobilizing potential.
  • Molecular docking studies of the lead compound into the CXCR4 crystal structure.

Main Results:

  • A novel series of pyrimidine-based CXCR4 antagonists was successfully synthesized.
  • Compound 16 exhibited favorable tolerability at high doses and superior HSC-mobilizing capacity compared to the approved drug AMD3100.
  • Molecular docking revealed a unique 'spider-like' binding conformation of compound 16 within the CXCR4 receptor.

Conclusions:

  • Pyrimidine-based compound 16 represents a promising drug candidate for peripheral blood stem cell transplantation (PBSCT) due to its enhanced HSC-mobilizing properties.
  • The elucidated binding mode offers valuable insights for the rational design of future CXCR4-targeting therapeutics.

More Related Videos

Generation of Integration-free Induced Pluripotent Stem Cells from Human Peripheral Blood Mononuclear Cells Using Episomal Vectors09:45

Generation of Integration-free Induced Pluripotent Stem Cells from Human Peripheral Blood Mononuclear Cells Using Episomal Vectors

Published on: January 1, 2017

11.5K
Isolation and Transplantation of Hematopoietic Stem Cells HSCs20:38

Isolation and Transplantation of Hematopoietic Stem Cells HSCs

Published on: February 25, 2007

24.3K

Related Concept Videos

Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.7K
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
5.3K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.2K
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.9K
Zygotic Development And Stem Cell Formation01:10

Zygotic Development And Stem Cell Formation

The development of all multicellular organisms starts with the fusion of haploid cells called sperm and egg to form a diploid zygote. A zygote is a totipotent cell that can develop into a complete organism. The zygote undergoes cell division or cleavage to form an 8-cell mass. Until this stage, the cells are spherical, loosely attached, and remain totipotent. Totipotent cells are capable of developing both the embryonic and the extraembryonic tissues. However, as they continue to divide, they...
6.9K
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells01:18

Distinctive Features of Adult Stem Cells vs Cancer Stem Cells

A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
4.5K